A comparative bibliometric analysis of natural product-based combination therapies in lung cancer: Insights into analytical strategies and translational challenges
Current Pharmaceutical Analysis · 2026-11 · 22 (9) · 833-849
DOI: 10.1016/j.cpan.2026.09.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Pharmaceutical Analysis, 2026-11. Verfasst von Chuanlong Zhang und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Natural Science Foundation, Capital Medical University Affiliated Beijing Friendship Hospital.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Beijing Natural Science Foundation
- Capital Medical University Affiliated Beijing Friendship Hospital
Zitieren
APA
Zhang, C., Gao, M., Zhang, X., Che, C., Cao, X., Zhang, L., & Wang, Z. (2026). A comparative bibliometric analysis of natural product-based combination therapies in lung cancer: Insights into analytical strategies and translational challenges. Current Pharmaceutical Analysis, 22(9), 833-849. https://doi.org/10.1016/j.cpan.2026.09.014
Vancouver
Zhang C, Gao M, Zhang X, Che C, Cao X, Zhang L, et al. A comparative bibliometric analysis of natural product-based combination therapies in lung cancer: Insights into analytical strategies and translational challenges. Current Pharmaceutical Analysis. 2026;22(9):833-849. doi:10.1016/j.cpan.2026.09.014
BibTeX
@article{Zhang2026,
author = {Zhang, Chuanlong and Gao, Mengqi and Zhang, Xiyuan and Che, Chang and Cao, Xuanye and Zhang, Lin and Wang, Ziheng},
title = {A comparative bibliometric analysis of natural product-based combination therapies in lung cancer: Insights into analytical strategies and translational challenges},
journal = {Current Pharmaceutical Analysis},
year = {2026},
volume = {22},
number = {9},
pages = {833--849},
doi = {10.1016/j.cpan.2026.09.014}
}
EUVIMED